JULIE SIMS: Open Payments
NPI 1467944645 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 64 payments from 14 companies in 2025. Trend: 2023 $911 · 2024 $915 · 2025 $1,123
Food & beverage: $1,013Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $279 |
| ABBVIE INC. | 17 | $216 |
| Galderma Laboratories, L.P. | 8 | $155 |
| UCB, Inc. | 8 | $142 |
| Organon LLC | 5 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $48 |
| Incyte Corporation | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $31 |
| Lilly USA, LLC | 2 | $29 |
Products named: TREMFYA, SKYRIZI, Bimzelx, NEMLUVIO, DUPIXENT, OPZELURA, Sotyktu, Winlevi.
Industry payments across DE — which companies pay providers there.
